Biotec

Biote CEO: "It takes a lot of time and a lot of capital to work your way through this whole process, right? It's kind of a big gamble, but it's like an informed gamble" He says he thinks there will be more talent that comes in over the next few years. The company is now working with FDA on its first compound for cancer treatment called thcumencs.